# CTS Corporation account plan

> CTS Corporation makes sensors, actuators and connectivity components for transportation, industrial, medical and defense; FY2025 sales $541.3 million.

## At a glance

CTS Corporation (NYSE: CTS), founded in 1896 and based in Lisle, Illinois, designs and makes sensors, actuators and connectivity components that "Sense, Connect or Move". It sells mainly to OEMs and tier one suppliers in aerospace and defense, industrial, medical and transportation, and to the U.S. Government, with plants in the US, Mexico, China, Taiwan, the Philippines, the Czech Republic, Poland and Denmark. FY2025 net sales were $541.3 million (+5.2%), operating earnings $82.6 million and net earnings $65.3 million, with 43.7% of sales from non-U.S. operations. It had 3,492 employees at December 31, 2025 and reports a single segment.

## Business units

- **Transportation** (43% of FY2025 net sales ($233.9 million)): Controls, pedals, sensors, switches and rotary actuators for vehicle OEMs and tier one suppliers, including Toyota Motor Corporation (11.2% of 2025 sales) and Cummins (8.4%). Sales fell 6.6% in 2025 on lower commercial vehicle volumes and customers' loss of share in China, then grew 1.7% in Q3 2026; booked business is about $1.2 billion.
- **Industrial** (26% of FY2025 net sales ($140.1 million)): Sensors, EMI/RFI filters, capacitors, frequency control products and resistors sold to industrial OEMs and through distributors. Sales recovered in 2025 from $125.4 million and rose to $39.8 million in Q3 2026, with design wins in data center applications, HVAC and industrial automation.
- **Medical** (16% of FY2025 net sales ($84.6 million)): Piezo sensing products, transducers and piezo microactuators for medical OEMs in diagnostic imaging, aesthetics and minimally invasive surgery, supported by the Ferroperm piezoceramics business in Denmark. Q3 2026 sales were $26.6 million, and the October 2026 Millar acquisition adds pressure sensing for medical devices.
- **Aerospace and Defense** (15% of FY2025 net sales ($82.8 million)): Sensors, filters and connectivity components for defense primes and the U.S. Government, including naval sonar from SyQwest, acquired in July 2024. CTS is moving from components to subsystems for naval sonar, undersea warfare and secure communications; Q3 2026 sales were $23.6 million with a book-to-bill of 1.91.

## Strategic priorities

- **Diversification away from transportation**: Grow industrial, medical and aerospace and defense, which reached 60% of sales in Q3 2026; transportation fell to 43% of FY2025 sales from 55% in 2023.
- **Acquisitions in advanced sensing**: CTS explores acquisitions on an ongoing basis; after TEWA, Ferroperm, Maglab and SyQwest it bought Millar Holdings in October 2026.
- **Defense subsystems**: Move from components to higher-value sensing solutions and integrated subsystems for naval sonar, undersea warfare and secure communications, including production scaling for a U.S. Navy undersea warfare application.
- **Powertrain-agnostic vehicle products**: Pursue the seat track market with Japanese OEMs, e-brake opportunities on hybrid and electric platforms and smart actuator approvals on new engine platforms expected around the middle of 2027, under the Evolution 2030 initiative.
- **Operational execution and margins**: Gross margin reached 42.2% in Q3 2026 against 38.4% for FY2025, and management aims to keep expanding gross margins in the mid- to long term.

## Latest results

In Q3 2026 (quarter to September 30, 2026) net sales rose 4.6% to $149.6 million, with diversified end markets up 6.6% and transportation up 1.7%. Gross margin reached 42.2% (38.7% a year earlier) and operating earnings $25.5 million (17.1% of sales); diluted EPS was $0.61 versus $0.46. For the nine months, sales were $433.6 million (+7.3%) and diluted EPS $1.87. Book-to-bill was 1.18. Full-year 2026 guidance was raised to sales of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88, though the CFO expects some normalization in profitability in the next few quarters.

## Investments and deals

- **Millar acquisition**: Acquired on October 23, 2026 for $50 million plus up to $20 million of contingent consideration, paid from cash; about $30 million of annual revenue expected, accretive in the second half of 2027.
- **SyQwest acquisition**: Naval sonar maker acquired July 2024 for $121.9 million cash; it added $22.3 million of 2025 net sales.
- **New credit facility**: Unsecured five-year $300 million revolving credit facility signed November 24, 2025, replacing a $400 million facility.
- **Share repurchases**: $56.2 million of buybacks in 2025 and a new $100 million program approved November 7, 2025; $15.2 million repurchased in the first nine months of 2026.
- **Medical capacity**: Medical capacity installed ahead of demand in aesthetics on long-term customer forecasts, per the Q1 2026 call.

## Challenges and risks

- **Customer concentration**: Toyota Motor Corporation and Cummins represented 11.2% and 8.4% of 2025 net sales, and customers can cancel orders or change volumes.
- **Cyclical transportation demand**: Transportation sales fell 6.6% in 2025, and global light vehicle production is expected flat to modestly down given tariff, geopolitical and consumer uncertainty.
- **Input costs and tariffs**: Inflation in precious metals, oil-derived resin and epoxy, transportation costs and Section 232 steel and aluminum tariffs; semiconductors and rare earth elements come from a limited number of suppliers.
- **Defense contract timing**: Aerospace and defense sales fell to $23.6 million in Q3 2026 from $25.4 million on the timing of contract awards, and defense contracts may be suspended or delayed.
- **Environmental liabilities**: CTS is named at several sites including Superfund sites, and the Asheville, North Carolina EPA matter continues under a 2017 consent decree.

## What leadership says

> "another important step in our strategy to reshape CTS towards a more diversified portfolio of high-value differentiated technologies serving attractive end markets." — Pratik Trivedi, President and Chief Executive Officer, Q3 2026 earnings call, October 27, 2026, on the Millar acquisition

> "We expect some normalization in profitability in the next few quarters." — Ashish Agrawal, Chief Financial Officer, Q3 2026 earnings call, October 27, 2026

> "Diversification remains a strategic priority to drive growth and margin expansion" — Kieran O'Sullivan, then Chairman, President and CEO, Q1 2026 earnings call, April 29, 2026, his last as CEO


## Where a supplier can help

- **Integration of acquired businesses**: Tied to the acquisition priority and the Millar deal: integrating Millar's design, microfabrication and manufacturing into CTS calls for systems, reporting and supply-chain support.
- **Supply chain resilience**: Tied to the input cost and tariff challenge: alternative sourcing for semiconductors, rare earth elements and precious metals, and tariff management tools, support the goal of keeping margins cost neutral.
- **Defense manufacturing scale-up**: Tied to the defense subsystems priority: scaling production for naval sonar and undersea warfare needs test equipment, compliance and precision manufacturing capacity.
- **Medical OEM growth**: Tied to the diversification priority: suppliers of materials, clean manufacturing and regulatory services can support growth in diagnostic imaging, aesthetics and catheter-based technologies.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [CTS Corporation Annual Report on Form 10-K for fiscal year 2025](https://www.sec.gov/Archives/edgar/data/26058/000119312526067039/cts-20251231.htm)

Annual report · 2026-02-24

- CTS Corporation (NYSE: CTS, Lisle, Illinois; founded 1896) designs and makes sensors, actuators and connectivity components that "Sense, Connect or Move", sold mainly to OEMs and tier one suppliers in aerospace and defense, industrial, medical and transportation, and to the U.S. Government.
- FY2025 net sales were $541.3 million, up 5.2%; gross margin 38.4% (36.4% in 2024); operating earnings $82.6 million; net earnings $65.3 million; diluted EPS $2.19 (vs $1.81).
- Diversified end markets grew 16.3% while transportation fell 6.6%; transportation is now 43% of sales (55% in 2023), industrial 26%, medical 16%, aerospace and defense 15%.
- Customer concentration: Toyota Motor Corporation 11.2% and Cummins 8.4% of 2025 net sales; about 86% of sales go through CTS's own sales engineers, about 7% through distributors (Avnet, Digi-Key, TTI and others).
- One reportable segment; 3,492 employees (1,875 North America, 1,099 Asia, 518 Europe); plants in the US, Mexico, China, Taiwan, Philippines, Czech Republic, Poland and Denmark; 43.7% of sales from non-U.S. operations.
- M&A drives the diversification: SyQwest (naval sonar, acquired July 2024 for $121.9 million cash) added $22.3 million of 2025 sales; earlier deals were TEWA, Ferroperm and Maglab.
- Cash: operating cash flow $102.1 million, capex $15.7 million, $56.2 million of buybacks; debt cut from $92.3 million to $57.5 million; new $300 million five-year revolver signed November 24, 2025 and a new $100 million buyback program.
- Leadership: Kieran O'Sullivan, Chairman, President and CEO; Ashish Agrawal, CFO; Pratik Trivedi appointed COO effective December 5, 2025; Mark Pacioni, Chief Legal and Administrative Officer.
- Key risks named: dependence on a few customers, cyclical transportation demand, tariffs and trade policy, supply of semiconductors and rare earth elements, defense contract timing, goodwill ($209.6 million), and environmental (EPA Superfund) liabilities.

### [CTS Corporation Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/26058/000119312526433661/cts-20260930.htm)

Interim report · 2026-10-27

- Q3 2026 (quarter to September 30, 2026) net sales were $149.6 million, up 4.6% year on year; diversified end markets up 6.6%, transportation up 1.7%.
- Q3 sales by end market: transportation $59.6 million, industrial $39.8 million, medical $26.6 million, aerospace and defense $23.6 million (down from $25.4 million on timing of contract awards).
- Q3 gross margin 42.2% (38.7% a year earlier) on improved end-market mix, operational improvements and about $1.4 million of favorable FX; operating earnings $25.5 million (17.1% of sales).
- Q3 net earnings $17.8 million, diluted EPS $0.61 (vs $0.46), helped by a $12.5 million representations and warranties insurance claim but hit by a 53.5% tax rate from reserves for an uncertain tax position.
- Nine months 2026: sales $434 million (+7.3%), gross margin 41.1%, net earnings $54.1 million, diluted EPS $1.87 (vs $1.52); operating cash flow $94.3 million.
- Cash $143.9 million and long-term debt $55.0 million at September 30, 2026; $15.2 million of buybacks in nine months.
- Pratik Trivedi became President and CEO on July 6, 2026, succeeding Kieran O'Sullivan, who stays on the Board as Executive Chair.
- On October 23, 2026 CTS acquired Millar Holdings (pressure sensing for medical devices, life sciences and industrial) for $50 million plus up to $20 million of earnout, paid from cash on hand.

### [CTS Corporation Q3 2026 earnings call transcript](https://s29.q4cdn.com/203066540/files/content_files/CTS-Corporation_Earnings-Call_2026-10-27_English_Q3_2026.pdf)

Executive talk · Pratik Trivedi, President and Chief Executive Officer · 2026-10-27

- First earnings call as CEO for Pratik Trivedi (promoted July 2026); Q3 2026 revenue up 5% to $150 million, diversified end markets 60% of sales.
- Record profitability: gross margin 42.2% (up 330 bps), adjusted EBITDA margin 24.7%, adjusted diluted EPS $0.77 vs $0.60.
- Book-to-bill 1.18, diversified 1.3; aerospace and defense 1.91, industrial 1.36, medical 0.66 on order timing; transportation booked business about $1.2 billion.
- Millar acquisition: about $30 million annual revenue expected, paid entirely in cash, gross-margin accretive and EPS accretive in the second half of 2027; expands into pressure, chemical and electrochemical sensing and catheter-based technologies.
- 2026 guidance raised to sales of $580-590 million and adjusted diluted EPS of $2.78-2.88.
- CFO Ashish Agrawal warns of "some normalization in profitability in the next few quarters" after an above-normal end-market mix.
- Defense: scaling production of a sensing solution for a U.S. Navy undersea warfare application; moving from components to subsystems for naval sonar, undersea warfare and secure communications.
- Transportation: entry into the seat track market with Japanese OEMs, floor-hinged pedals into China, e-brake opportunities on hybrid and electric platforms; smart actuator approvals on new engine platforms expected around mid-2027.

### [CTS Corporation Q1 2026 earnings call transcript](https://www.fool.com/earnings/call-transcripts/2026/04/29/cts-cts-q1-2026-earnings-call-transcript/)

Executive talk · Kieran O'Sullivan, Chairman, President and Chief Executive Officer · 2026-04-29

- Last earnings call led by Kieran O'Sullivan as Chairman, President and CEO (April 29, 2026), with CFO Ashish Agrawal and COO Pratik Trivedi.
- Q1 2026 sales $139 million, up 11%; diversified end markets up 18%, transportation up 3%; book-to-bill 1.1; adjusted diluted EPS $0.62 vs $0.44; adjusted gross margin 39.5% (up 250 bps).
- End markets: medical $25 million (+28%, book-to-bill 1.2), industrial $37 million (+14%, book-to-bill 1.29), aerospace and defense $17 million (+11%), transportation $60 million (+3%).
- Wins: an underwater hull penetrator contract worth around $20 million over five years, two new RF filter customers for secure communications, an accelerometer award from a North American OEM, foot controls in China, Japan, Europe and North America.
- 2026 guidance then: sales $560-580 million, adjusted diluted EPS $2.35-2.45.
- Cost pressures named: precious metals, oil-derived resin and epoxy, transportation costs, Section 232 steel and aluminum tariffs; goal to keep margins "cost neutral".
- Margin profile: diversified markets beat transportation, "medical is definitely the strongest end market"; medical capacity installed ahead of demand in aesthetics, expecting double-digit sales growth.
- Strategy: diversification, "powertrain-agnostic" vehicle solutions and the "Evolution 2030" initiative; M&A "very active" though nothing to report.

## Questions about CTS Corporation

### What does CTS Corporation do?

CTS designs and makes sensors, actuators and connectivity components that "Sense, Connect or Move", sold to OEMs and tier one suppliers in aerospace and defense, industrial, medical and transportation, and to the U.S. Government.

### What is CTS Corporation's revenue?

FY2025 net sales were $541.3 million, up 5.2%. Guidance for 2026 was raised in October 2026 to $580 million to $590 million.

### How many employees does CTS Corporation have?

3,492 at December 31, 2025: 1,875 in North America, 1,099 in Asia and 518 in Europe.

### Who is the CEO of CTS Corporation?

Pratik Trivedi became President and CEO on July 6, 2026, succeeding Kieran O'Sullivan, who remains on the Board as Executive Chair. Ashish Agrawal is CFO.

### What is CTS Corporation's strategy?

CTS is diversifying away from transportation toward industrial, medical and aerospace and defense through organic growth and acquisitions such as SyQwest and Millar, while developing powertrain-agnostic vehicle products.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
